195 related articles for article (PubMed ID: 36602354)
1. Atypical Mutational Spectrum of SARS-CoV-2 Replicating in the Presence of Ribavirin.
Somovilla P; García-Crespo C; Martínez-González B; Soria ME; de Ávila AI; Gallego I; Mínguez P; Durán-Pastor A; Ferrer-Orta C; Salar-Vidal L; Esteban-Muñoz M; Zuñiga S; Sola I; Enjuanes L; Esteban J; Fernandez-Roblas R; Gadea I; Gómez J; Verdaguer N; Domingo E; Perales C
Antimicrob Agents Chemother; 2023 Jan; 67(1):e0131522. PubMed ID: 36602354
[TBL] [Abstract][Full Text] [Related]
2. Ribavirin shows antiviral activity against SARS-CoV-2 and downregulates the activity of TMPRSS2 and the expression of ACE2 in vitro.
Unal MA; Bitirim CV; Summak GY; Bereketoglu S; Cevher Zeytin I; Besbinar O; Gurcan C; Aydos D; Goksoy E; Kocakaya E; Eran Z; Murat M; Demir N; Aksoy Ozer ZB; Somers J; Demir E; Nazir H; Ozkan SA; Ozkul A; Azap A; Yilmazer A; Akcali KC
Can J Physiol Pharmacol; 2021 May; 99(5):449-460. PubMed ID: 33689451
[TBL] [Abstract][Full Text] [Related]
3. Counteracting quasispecies adaptability: extinction of a ribavirin-resistant virus mutant by an alternative mutagenic treatment.
Perales C; Agudo R; Domingo E
PLoS One; 2009; 4(5):e5554. PubMed ID: 19436746
[TBL] [Abstract][Full Text] [Related]
4. Mutagenic effect of ribavirin on hepatitis C nonstructural 5B quasispecies in vitro and during antiviral therapy.
Hofmann WP; Polta A; Herrmann E; Mihm U; Kronenberger B; Sonntag T; Lohmann V; Schönberger B; Zeuzem S; Sarrazin C
Gastroenterology; 2007 Mar; 132(3):921-30. PubMed ID: 17383421
[TBL] [Abstract][Full Text] [Related]
5. Inhibitory effect of mizoribine and ribavirin on the replication of severe acute respiratory syndrome (SARS)-associated coronavirus.
Saijo M; Morikawa S; Fukushi S; Mizutani T; Hasegawa H; Nagata N; Iwata N; Kurane I
Antiviral Res; 2005 Jun; 66(2-3):159-63. PubMed ID: 15911031
[TBL] [Abstract][Full Text] [Related]
6. Lethal Mutagenesis of RNA Viruses and Approved Drugs with Antiviral Mutagenic Activity.
Hadj Hassine I; Ben M'hadheb M; Menéndez-Arias L
Viruses; 2022 Apr; 14(4):. PubMed ID: 35458571
[TBL] [Abstract][Full Text] [Related]
7. Extinction of hepatitis C virus by ribavirin in hepatoma cells involves lethal mutagenesis.
Ortega-Prieto AM; Sheldon J; Grande-Pérez A; Tejero H; Gregori J; Quer J; Esteban JI; Domingo E; Perales C
PLoS One; 2013; 8(8):e71039. PubMed ID: 23976977
[TBL] [Abstract][Full Text] [Related]
8. Influence of Ribavirin on Mumps Virus Population Diversity.
Jurković M; Slović A; Forčić D; Ivančić-Jelečki J; Košutić-Gulija T; Jagušić M
Viruses; 2021 Dec; 13(12):. PubMed ID: 34960805
[TBL] [Abstract][Full Text] [Related]
9. β-d-N4-hydroxycytidine Inhibits SARS-CoV-2 Through Lethal Mutagenesis But Is Also Mutagenic To Mammalian Cells.
Zhou S; Hill CS; Sarkar S; Tse LV; Woodburn BMD; Schinazi RF; Sheahan TP; Baric RS; Heise MT; Swanstrom R
J Infect Dis; 2021 Aug; 224(3):415-419. PubMed ID: 33961695
[TBL] [Abstract][Full Text] [Related]
10. Ribavirin and lethal mutagenesis of poliovirus: molecular mechanisms, resistance and biological implications.
Vignuzzi M; Stone JK; Andino R
Virus Res; 2005 Feb; 107(2):173-81. PubMed ID: 15649563
[TBL] [Abstract][Full Text] [Related]
11. Remdesivir, lopinavir, emetine, and homoharringtonine inhibit SARS-CoV-2 replication in vitro.
Choy KT; Wong AY; Kaewpreedee P; Sia SF; Chen D; Hui KPY; Chu DKW; Chan MCW; Cheung PP; Huang X; Peiris M; Yen HL
Antiviral Res; 2020 Jun; 178():104786. PubMed ID: 32251767
[TBL] [Abstract][Full Text] [Related]
12. Potential benefits of sequential inhibitor-mutagen treatments of RNA virus infections.
Perales C; Agudo R; Tejero H; Manrubia SC; Domingo E
PLoS Pathog; 2009 Nov; 5(11):e1000658. PubMed ID: 19911056
[TBL] [Abstract][Full Text] [Related]
13. Coronaviruses lacking exoribonuclease activity are susceptible to lethal mutagenesis: evidence for proofreading and potential therapeutics.
Smith EC; Blanc H; Surdel MC; Vignuzzi M; Denison MR
PLoS Pathog; 2013 Aug; 9(8):e1003565. PubMed ID: 23966862
[TBL] [Abstract][Full Text] [Related]
14. Extinction of Zika Virus and Usutu Virus by Lethal Mutagenesis Reveals Different Patterns of Sensitivity to Three Mutagenic Drugs.
Bassi MR; Sempere RN; Meyn P; Polacek C; Arias A
Antimicrob Agents Chemother; 2018 Sep; 62(9):. PubMed ID: 29914957
[TBL] [Abstract][Full Text] [Related]
15. Viral Polymerase-Helicase Complexes Regulate Replication Fidelity To Overcome Intracellular Nucleotide Depletion.
Stapleford KA; Rozen-Gagnon K; Das PK; Saul S; Poirier EZ; Blanc H; Vidalain PO; Merits A; Vignuzzi M
J Virol; 2015 Nov; 89(22):11233-44. PubMed ID: 26311883
[TBL] [Abstract][Full Text] [Related]
16. Effect of ribavirin on the frequency of RNase L cleavage sites within the hepatitis C viral genome.
Mihm U; Hofmann WP; Welsch C; Polta A; Lengauer T; Zeuzem S; Sarrazin C; Herrmann E
J Viral Hepat; 2010 Mar; 17(3):217-21. PubMed ID: 19758279
[TBL] [Abstract][Full Text] [Related]
17. Isolation of SARS-CoV-2 from COVID-19 Patients and an Asymptomatic Individual.
Hishiki T; Usui K; An T; Suzuki R; Sakuragi JI; Tanaka Y; Matsuki Y; Kawai J; Kogo Y; Hayashizaki Y; Takasaki T
Jpn J Infect Dis; 2022 May; 75(3):277-280. PubMed ID: 34719530
[TBL] [Abstract][Full Text] [Related]
18. Cysteamine with In Vitro Antiviral Activity and Immunomodulatory Effects Has the Potential to Be a Repurposing Drug Candidate for COVID-19 Therapy.
Alonzi T; Aiello A; Petrone L; Najafi Fard S; D'Eletto M; Falasca L; Nardacci R; Rossin F; Delogu G; Castilletti C; Capobianchi MR; Ippolito G; Piacentini M; Goletti D
Cells; 2021 Dec; 11(1):. PubMed ID: 35011614
[TBL] [Abstract][Full Text] [Related]
19. Arenaviruses and lethal mutagenesis. Prospects for new ribavirin-based interventions.
Moreno H; Grande-Pérez A; Domingo E; Martín V
Viruses; 2012 Nov; 4(11):2786-805. PubMed ID: 23202505
[TBL] [Abstract][Full Text] [Related]
20. In vitro and in vivo activity of ribavirin against Andes virus infection.
Safronetz D; Haddock E; Feldmann F; Ebihara H; Feldmann H
PLoS One; 2011; 6(8):e23560. PubMed ID: 21853152
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
